Vitara-V 20 mg Vardenafil Tablets

Vitara-V 20 mg Vardenafil Tablets

Vitara-V 20 mg Vardenafil Tablets is presented here solely for factual product-label information. Its stated composition and strength must be verified against the original packaging and official manufacturer documentation. Vardenafil is a phosphodiesterase type 5 (PDE5) inhibitor used in adult men for erectile dysfunction. It improves the erectile response during sexual stimulation; sexual stimulation is still required.

Product details

• Active ingredient: Vardenafil
• Labelled strength: 20 mg
• Dosage form: Tablet
• Reference indication: Erectile dysfunction in adult men, following assessment by a licensed healthcare professional

Before use

Use only on the advice of a licensed prescriber and exactly as directed in the product-specific patient leaflet. A clinician should review cardiovascular health, blood pressure, recent heart attack or stroke, liver and kidney function, eye history, and every medicine or recreational substance used. Do not combine with sildenafil, tadalafil, or another erectile-dysfunction treatment.

Important safety information

Never use vardenafil with nitrates used for chest pain, nitric-oxide donors such as amyl nitrite (“poppers”), or riociguat. Vardenafil is also contraindicated in several serious cardiovascular, liver, kidney, and retinal conditions. It has important interactions with some potent CYP3A4 inhibitors, including certain antifungal and HIV medicines; a doctor or pharmacist must check the full medication list.

Commonly reported effects include headache, flushing, nasal congestion, indigestion, and dizziness. Stop use and obtain urgent medical help for chest pain, fainting, severe allergy, sudden loss of vision or hearing, or an erection lasting more than four hours.

Storage and quality checks

Keep in the original packaging, out of the sight and reach of children, and protect from heat and moisture. Check that the tamper seal, batch details, and expiry date are intact and legible. Do not use a damaged or visibly altered package.

Regulatory notice

Reference information on this page concerns vardenafil. The exact authorization, dispensing classification, approved presentation, and permitted sale of this branded product depend on its manufacturer documentation and the destination country. Local prescription and pharmacy rules must be followed.

This information does not replace the supplied patient leaflet or advice from a doctor or pharmacist.

Medical reference: European Medicines Agency — Levitra (vardenafil)